test

Mark Gottlieb

@Altium Capital Management Lp

Latest period2024 - Q3ReportedManaged Assets$339.708MTotal holdings77
Assets growth rate-99.86%Assets growth rate (2-Q avg)-51.42%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Altium Capital Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 77 positions.

Assets under management

The assets under management (AUM) of Altium Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 339.708M in assets, with a quarterly growth rate of -99.86% and a 2-quarter average growth rate of -51.42%. The portfolio is managed by Mark Gottlieb, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
SRPTSarepta Therapeutics Inc
Recent Activity
Increased 107.58%
6.25%
$21.231M
170,000 shares@ $124.89 avg price
XENEXenon Pharmaceuticals Inc
Recent Activity
Increased 2.61%
4.29%
$14.567M
370,000 shares@ $39.37 avg price
ZVRAZevra Therapeutics Inc
Recent Activity
Increased 46.25%
3.48%
$11.798M
1.7M shares@ $6.94 avg price
VKTXViking Therapeutics Inc
Recent Activity
Increased 3.28%
2.35%
$7.977M
126,000 shares@ $63.31 avg price
AXSMAxsome Therapeutics Inc
Recent Activity
Increased 16%
1.54%
$5.212M
58,000 shares@ $89.87 avg price
REALThe Realreal Inc
Recent Activity
Increased 1.59%
1.18%
$3.988M
1.27M shares@ $3.14 avg price
CATXPerspective Therapeutics Inc
Recent Activity
Increased 51.48%
1.14%
$3.871M
290,000 shares@ $13.35 avg price
OTLKOutlook Therapeutics Inc
Recent Activity
Increased 7.93%
0.86%
$2.892M
541,549 shares@ $5.35 avg price
ANVSAnnovis Bio Inc
Recent Activity
Increased 52.23%
0.57%
$1.905M↓ Put
236,400 shares@ $8.06 avg price